Fouace Sandra, Gaudin Cyril, Picard Sylvie, Corvaisier Sophie, Renault Jacques, Carboni Bertrand, Felden Brice
SESO, UMR 6510 CNRS, Institut de Chimie, Université de Rennes 1, F-35042 Rennes Cedex, France.
Nucleic Acids Res. 2004 Jan 2;32(1):151-7. doi: 10.1093/nar/gkh157. Print 2004.
Site-selective scission of ribonucleic acids (RNAs) has attracted considerable interest, since RNA is an intermediate in gene expression and the genetic material of many pathogenic viruses. Polyamine-imidazole conjugates for site-selective RNA scission, without free imidazole, were synthesized and tested on yeast phenylalanine transfer RNA. These molecules catalyze RNA hydrolysis non-randomly. Within the polyamine chain, the location of the imidazole residue, the numbers of nitrogen atoms and their relative distances have notable influence on cleavage selectivity. A norspermine derivative reduces the cleavage sites to a unique location, in the anticodon loop of the tRNA, in the absence of complementary sequence. Experimental results are consistent with a cooperative participation of an ammonium group of the polyamine moiety, in addition to it's binding to the negatively charged ribose-phosphate backbone, as proton source, and the imidazole moiety as a base. There is correlation between the location of the magnesium binding sites and the RNA cleavage sites, suggesting that the protonated nitrogens of the polycationic chain compete with some of the magnesium ions for RNA binding. Therefore, the cleavage pattern is specific of the RNA structure. These compounds cleave at physiological pH, representing novel reactive groups for antisense oligonucleotide derivatives or to enhance ribozyme activity.
核糖核酸(RNA)的位点选择性切割引起了广泛关注,因为RNA是基因表达的中间体以及许多致病病毒的遗传物质。合成了无游离咪唑的用于位点选择性RNA切割的多胺-咪唑缀合物,并在酵母苯丙氨酸转移RNA上进行了测试。这些分子非随机地催化RNA水解。在多胺链中,咪唑残基的位置、氮原子的数量及其相对距离对切割选择性有显著影响。一种降精胺衍生物在没有互补序列的情况下将切割位点减少到tRNA反密码子环中的一个独特位置。实验结果与多胺部分的铵基团除了作为质子源与带负电荷的核糖-磷酸主链结合外,还作为碱与咪唑部分协同参与的情况一致。镁结合位点的位置与RNA切割位点之间存在相关性,表明聚阳离子链的质子化氮与一些镁离子竞争RNA结合。因此,切割模式是RNA结构特有的。这些化合物在生理pH下切割,代表了反义寡核苷酸衍生物的新型反应基团或增强核酶活性。